Navellier & Associates Inc Novo Nordisk A S Transaction History
Navellier & Associates Inc
- $792 Million
- Q4 2024
A detailed history of Navellier & Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Navellier & Associates Inc holds 5,082 shares of NVO stock, worth $352,182. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,082
Previous 118,465
95.71%
Holding current value
$352,182
Previous $14.1 Million
96.9%
% of portfolio
0.06%
Previous 2.0%
Shares
8 transactions
Others Institutions Holding NVO
# of Institutions
1,886Shares Held
335MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.38 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.07 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$901 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$876 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$846 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $156B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...